methylprednisolone oral / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylprednisolone oral / Generic mfg.
2020-004534-38: A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment

Not yet recruiting
2
300
Europe
DUR-928 30mg, DUR-928 90mg, Methylprednisolone, DUR-928, NDC 59762-0051-1, Concentrate for solution for infusion, Capsule, hard + tablet, Methylprednisolone
DURECT Corporation, DURECT Corporation
Alcoholic hepatitis, Damage to your liver due to drinking too much alcohol over a long period of time, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
IMPACT-2, NCT06215261: An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD

Not yet recruiting
2
79
RoW
Methylone, Placebo
Transcend Therapeutics
Post Traumatic Stress Disorder
12/25
12/25
IMPACT-EXT, NCT06237426: An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD

Enrolling by invitation
2
150
Europe
Methylone
Transcend Therapeutics
Post Traumatic Stress Disorder
05/27
05/27
NCT04918953: Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation

Not yet recruiting
2
90
RoW
methylprednisolone, Olfactory training, budesonide atomization suspension
Second Affiliated Hospital, School of Medicine, Zhejiang University
Outcome
12/25
12/26
IMPACT-1, NCT05741710: A Study to Assess the Use of Methylone in the Treatment of PTSD

Recruiting
1/2
79
Europe
Methylone, Placebo
Transcend Therapeutics
Post Traumatic Stress Disorder
12/24
12/24

Download Options